Trademark: 87093137
Status Date
Friday, January 26, 2024
Registration Number
5239739
Registration Date
Tuesday, July 11, 2017
Filing Date
Tuesday, July 5, 2016
Published for Opposition
Tuesday, March 7, 2017
Cancellation Date
Friday, January 26, 2024
5 Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of neuromuscular and ophthalmological diseases; Pharmaceutical preparations for the treatment of central nervous system-related conditions, neurological and muscular diseases, neuro-muscular diseases, muscular dystrophies, ataxias, amyotrophia, atrophy, ophthalmological diseases, muscle wasting, cardiomyopathies, optic nerve degradation, neurological indications, memory loss, Lou Gehrig's disease, Parkinson's disease, Huntington's disease, spinal muscular atrophies, polyneuropathies, fibromyalgia, mononeuropathies, neuromuscular junction disorders, myotonia and myopathies; reagents for medical use in connection with the aforementioned diseases
1 Active chemical ingredients for use in the manufacture of small molecule pharmaceuticals for treating neuromuscular and ophthalmological diseases; reagents for scientific and medical research for use in the research of small molecule pharmaceuticals and research of the treatment of neuromuscular and ophthalmological diseases; all of the foregoing excluding cleaning agents for use in laboratories and industries
42 Medical research; scientific research; medical and scientific research, namely, conducting clinical trials for others; computer programming for others for medical and science research purposes; scientific research for testing cell cultures and developing cellular test systems for evaluating new drugs and antibodies; developing test systems for detecting pharmacologically active compounds; genetic animal model testing and scientific research for neuro-muscular and ophthalmological diseases for research purposes
Jan 26, 2024
Cancelled Sec. 8 (6-Yr)
Jul 11, 2022
Courtesy Reminder - Sec. 8 (6-Yr) E-Mailed
Jun 20, 2018
Applicant/Correspondence Changes (Non-Responsive) Entered
Jun 20, 2018
Teas Change Of Owner Address Received
Jul 11, 2017
Registered-Principal Register
Jun 2, 2017
1(B) Basis Deleted; Proceed To Registration
May 11, 2017
Notice Of Allowance Cancelled
Jun 2, 2017
Case Assigned To Intent To Use Paralegal
May 11, 2017
Teas Post Publication Amendment Received
May 2, 2017
Noa E-Mailed - Sou Required From Applicant
Mar 7, 2017
Official Gazette Publication Confirmation E-Mailed
Mar 7, 2017
Published For Opposition
Feb 15, 2017
Notification Of Notice Of Publication E-Mailed
Jan 31, 2017
Law Office Publication Review Completed
Jan 25, 2017
Approved For Pub - Principal Register
Jan 24, 2017
Teas/Email Correspondence Entered
Jan 24, 2017
Correspondence Received In Law Office
Jan 17, 2017
Teas Response To Office Action Received
Dec 29, 2016
Notification Of Non-Final Action E-Mailed
Dec 29, 2016
Non-Final Action E-Mailed
Dec 29, 2016
Non-Final Action Written
Dec 29, 2016
Previous Allowance Count Withdrawn
Dec 23, 2016
Assigned To Lie
Nov 17, 2016
Approved For Pub - Principal Register
Nov 17, 2016
Teas/Email Correspondence Entered
Nov 17, 2016
Correspondence Received In Law Office
Nov 1, 2016
Assigned To Lie
Oct 26, 2016
Assigned To Lie
Oct 18, 2016
Teas Response To Office Action Received
Oct 18, 2016
Notification Of Examiner's Amendment/Priority Action E-Mailed
Oct 18, 2016
Examiner's Amendment/Priority Action E-Mailed
Oct 18, 2016
Combined Examiner's Amendment/Priority Action Automatic Entry
Oct 18, 2016
Examiners Amendment And/Or Priority Action - Completed
Oct 13, 2016
Assigned To Examiner
Jul 8, 2016
New Application Office Supplied Data Entered
Jul 8, 2016
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
